CANADA: Widespread HAART Treatment Reduces New HIV Infections

A new study just published in British Columbia suggests that a very effective way to prevent new HIV infections may be to put all pozzers on HAART therapy.

A new study conducted in British Columbia has found that the infection rate in the province has been halved since 1996 by the widespread adoption of HAART, researchers reported online Sunday in the journal Lancet and at the International AIDS Conference in Vienna. For every 100 new patients treated, the infection rate went down 3%, Dr. Julio Montaner, director of the British Columbia Centre for Excellence in HIV/AIDS, reported. “This study strengthens the evidence that maximizing HAART coverage within current medical guidelines will help to curb the spread of HIV,” Dr. Nora D. Volkow, director of the U.S. National Institute on Drug Abuse, said in a statement. The agency funded the study. “These findings are especially important since new HIV cases have remained stubbornly steady in the United States at a rate of about 56,000 per year for the past 10 years.” British Columbia is a good place for such a study because it is relatively small — population about 4,420,00 — and everyone in the province receives free medical care.

Earlier this year the San Francisco Health Department recommended patients begin HAART therapy immediately upon diagnosis, regardless of disease progression, a strategy that has been met with some controversy.